Clinical Trial Update: Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures [Phase 4]

View source ↗

Summary

Phase 4 trial update on emicizumab prophylaxis in participants with Hemophilia A undergoing minor surgery; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Emicizumab (emicizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Hemophilia A | Phase 4 | Status: TERMINATED | Results posted: 2021-03-01